[1] |
YU Saihong, ZHENG Xiaoliang, PU Yiyi, YAN Dongmei, WANG Xiaoju, YU Jie.
Reversal of 5-fluorouracil resistance in hepatocellular carcinoma cells by inhibiting ribonucleotide reductase M2
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(7): 729-737.
|
[2] |
LIANG Qing, WANG Hui.
Azone combined with menthol has penetration-promoting effect on 5-fluorouracil
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 734-739.
|
[3] |
SONG Haiyan, ZHANG Yimin, ZHOU Zhixin, CHENG Huixin, FU Shengqi.
Effect of obatoclax in combination with 5-fluorouracil on the apoptosis of pancreatic cancer cells under hypoxic
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(8): 887-891.
|
[4] |
HOU Xinfang, SONG Haiyan, ZHOU Zhixin, DENG XiaoHui, ZHANG Yimin, CHENG Huixin.
Effects of obatoclax plus 5-Fluorouracil on the epithelial mesenchymal transition of pancreatic cancer cells under hypoxia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(10): 1117-1122.
|
[5] |
WANG Ning, ZHANG Yang-de, LIAO Ming-mei, ZHAO Jin-feng, CHEN Wei.
Inhibitory effect of epirubcin hydrochloride co-treated with oxaliplatin in the apoptosis of HepG2 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(5): 490-494.
|
[6] |
HU Min, SHAO Ming-jun, HE Yun-qin, ZHOU Meng-xiong.
Clinical observation on effect of neoadjuvant chemotherapy with gemcitabine hydrochloride in patients with cervical cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(4): 454-457.
|
[7] |
ZHAO Wen-ying, JI Zhao-ning.
Comparison of 2-week regimen and 3-week regimen based on oxaliplatin plus 5-fluorouracil and Calcium folinate as the first-line in the reatment of metastatic colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(8): 930-933.
|
[8] |
WANG Suo-an, SONG Qing, ZHANG Xiao-wen, ZHAO Ming, LIU Yong-nian, ZHAO Hai-long, ZHANG Wei.
Study on apoptosis of human colorectal carcinoma cell line lovo induced by 5-Fluorouracil and its molecular mechanisms
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(8): 877-882.
|
[9] |
YU Dong-mei, HAO Li-jun, LI Ying, XIAO Zhi-bo, LIU Ying.
Effects of mitomycin C on proliferation and apoptosis of fibroblasts derived from keloid
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(8): 900-905.
|
[10] |
JIANG Yi, QIU Xi-hui, CHEN Zhi-ming, LIN Dan-xia, YANG Yu-xian.
Clinical evaluation of PLF and PFM regimens in recurrent or metastasis nasopharyngeal carcinona
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2006, 11(10): 1168-1172.
|
[11] |
MA Yu-guang, WU Li, WANG Yu-cheng, MA Da-chang, WU Li, WANG Li-jing.
Effects of 5-Fluorouracil on cell proliferation and potassium channel function in oral cancer cell line Tb
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 890-893.
|
[12] |
WANG Hui, XU Wei-Ming.
Effects ofl-menthol and its binary systems on thePercutaneousPenetration and the deposit effect of 5-fluorouracil1
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2003, 8(4): 422-424.
|